Short description
Clearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.
Description
Clearside BioMedical, an ophthalmic company, specializes in the research, development, and commercialization of therapeutic products through an ocular microinjection platform that targets the individual compartments of the eye. It provides a non-surgical application for dosing drugs to distinct eye tissues, such as the retina, trabecular meshwork, and corneal stroma. The company’s CLS1001 is under development for retinal applications through the delivery of therapeutics to the suprachoroidal space. Clearside BioMedical was incorporated in 2011 and is based in Atlanta, Georgia.
Last funding
Nopepepe
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Alpharetta, Georgia, United States, North America
Founded on
January 1, 2011
Exited on
June 2, 2016
Went public on
June 2, 2016
Stock symbol
CLSD
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access
Investors
Noaccess, Cannot Access, No Way, Uh Ohhhh, Noway Youcantaccess, Noaccessforu, Absolutely Noaccess, Noway Youcantaccess, Noaccess, Nopepepe, Cannot Access
Sign in for full access
Founders
Henry F. Edelhauser, Mark Prausnitz, Samirkumar Patel